The licensing, development and commercialization agreement is intended at rapidly advancing Pracinostat into phase III clinical development and expanding the treatment into further indications that include high-risk myelodysplastic
The company said it will fully assess the trial’s data and work with investigators on the future presentation of the results. The phase 3, open-label, randomized CheckMate -026
Under the lawsuit, filed in federal court in Delaware, AbbVie alleged that Amgen’s proposed ABP 501 biosimilar would infringe at least 10 of its patents. AbbVie also noted that
The Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee of the US Food and Drug Administration (FDA) voted 18 to 1 to
The companies have already signed contracts to exchange their respective animal health and consumer healthcare businesses. Sanofi will transfer ownership of the €11.4bn Merial animal health business to
Anda is currently the fourth-largest distributor of generic pharmaceuticals in the US. It delivers generic, brand, specialty, and over-the-counter pharmaceutical products from over 300 manufacturers to pharmacies. Under
The approval stipulates that patients whose tumors are EGFR or ALK positive should first receive an EFGR or ALK inhibitor, respectively, prior to treatment with Keytruda. The approved
The companies struck a collaboration deal for the development and commercialization of ADXS-NEO. Under the deal, Amgen will pay Advaxis $40m upfront along with a $25m equity investment.
The US Food and Drug Administration granted the designation to LEE011 in combination with letrozole for treating hormone receptor positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced
Adcetris, which is being developed jointly Seattle Genetics and Takeda, showed a highly statistically significant improvement in the rate of objective response lasting at least four months (ORR4).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.